Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The local tissue cells and extracellular matrix (ECM) at a wound site represent a complex, dynamic microenvironment essential for tissue regeneration and repair. This site includes a variety of cell types, such as fibroblasts, keratinocytes, endothelial cells, and infiltrating immune cells, all of which interact with a structural scaffold composed of collagen, proteoglycans, and glycoproteins [1][2]. The biological function of this environment is to coordinate the sequential phases of wound healing: hemostasis, inflammation, proliferation, and remodeling [3]. In chronic disease states like diabetes or venous insufficiency, this environment can become stalled in a pro-inflammatory state, leading to non-healing ulcers [4]. Therapeutic strategies often target this site using growth factors, enzymatic debridement, or advanced dressings to restore the balance of the ECM and promote cellular migration [5]. Drugs like Becaplermin interact with specific receptors on these local cells to stimulate healing, while enzymes like collagenase modify the matrix itself to remove necrotic tissue. Monitoring biomarkers such as matrix metalloproteinases within this environment can provide insight into the healing progress or the transition to a chronic state. Because this term describes a physiological location and a collection of diverse biological components rather than a single molecule, it is classified as a site of action rather than a specific therapeutic target. [1] https://www.ncbi.nlm.nih.gov/books/NBK470443/ [2] https://pmc.ncbi.nlm.nih.gov/articles/PMC4148380/ [3] https://www.nature.com/articles/nrd2462 [4] https://www.niddk.nih.gov/health-information/diabetes/overview/preventing-problems/foot-problems [5] https://pubchem.ncbi.nlm.nih.gov/compound/Becaplermin
Modulation of the wound microenvironment through growth factor signaling, enzymatic debridement of necrotic tissue, and provision of a scaffold for cellular migration and proliferation.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Local tissue cells and extracellular matrix at the wound site.